Genmab reported DKK1.83B in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Amarin AMRN:US $ 364.74M 5.69M
Amgen AMGN:US $ 14842M 257M
AstraZeneca AZN:LN 23649M 1427M
Bayer BAYN:GR € 28727M 801M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Exelixis EXEL:US $ 269.51M 14.18M
Fresenius Medical Care FME:GR € 7492M 67.37M
Galapagos GLPG:NA € 575.49M 1.49M
Genmab GEN:DC DK 1830M 479M
GlaxoSmithKline GSK:LN 22417M 1030M
GN Store Nord GN:DC DK 4969M 394M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 9.08B 646M
Hikma Pharmaceutical HIK:LN 960M 68M
Immunogen IMGN:US $ 111.78M 8.53M
Insmed INSM:US $ 112.5M 12.84M
Lonza Group LONN:SW 3.11B 12M
Merck MRK:GR € 9793M 27M
Novartis NOVN:VX SF 29880M 247M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Seattle Genetics SGEN:US $ 698.43M 264.6M
William Demant Holding WDH:DC 9.47B 2.1B